Accent Therapeutics presents ATX-295 data at AACR Annual Meeting 2026

10x Genomics introduces new in situ spatial biology platform

Whitehawk Therapeutics presents ADC preclinical data at AACR 2026

WuXi Biologics gains Morningstar Sustainalytics Industry and Regional ESG Leader recognition for sixth year

Kura Oncology reports early activity for darlifarnib–cabozantinib combination in cabozantinib‑pretreated ccRCC

European Commission approves Merck's ENFLONSIA for infant RSV prevention in Europe

Bold Therapeutics reports protection against chemotherapy-induced peripheral neuropathy with BOLD-100 anticancer agent

Adimab partner GSK receives additional marketing approvals for depemokimab

Seragon reports SRN-901 longevity drug data

Lunai Bioworks and Geneial enter into LOI to build rare disease patient cohorts for drug development partnerships

Circio partners with Acuitas to evaluate in vivo CAR-T cell therapy technology

GSK strengthens pulmonary hypertension pipeline with USD950m acquisition of 35Pharma

Poolbeg Pharma secures MHRA approval for POLB 001 trial as US research highlights multi-billion dollar potential

Asgard Therapeutics appoints chief medical officer

Mestag Therapeutics to present targeted LTBR agonist MST-0312 at AACR Annual Meeting